Statistics
Publications
3
Citations
52
H-Index
3
Active since
2022
Tengyun Li is an author at Nanjing Medical University specializing in pharmacology, oncology, and cancer drug delivery.
Publications per year
2022–2024
3
3
USP5 Promotes Ripretinib Resistance in Gastrointestinal Stromal Tumors by MDH2 Deubiquition
Haoyu Sun, Zhiwei Cui, Chao Li et al. · Advanced Science · 2024 · 18 citations · Full text
Medicine, Oncology, Pharmacology +17
Lijun Pang, Lei Zhang, Hong Zhou et al. · Frontiers in Chemistry · 2022 · 16 citations · Full text
1–3 of 3